We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
+9.02%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.27B
AUM Growth
+$957K
Cap. Flow
-$81.4M
Cap. Flow %
-6.43%
Top 10 Hldgs %
5.55%
Holding
1,966
New
431
Increased
565
Reduced
590
Closed
359

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$7.23M
2
LNKD
LinkedIn Corporation
LNKD
+$7.08M
3
PFE icon
Pfizer
PFE
+$6.7M
4
BBY icon
Best Buy
BBY
+$6.21M
5
PCYC
PHARMACYCLICS INC
PCYC
+$6.09M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$12.3M
2
HPQ icon
HP
HPQ
+$8.76M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$8.48M
4
BAX icon
Baxter International
BAX
+$6.78M
5
MPC icon
Marathon Petroleum
MPC
+$6.75M

Sector Composition

Rank Sector Weight
1 Industrials 12.7%
2 Healthcare 12.7%
3 Consumer Discretionary 11.82%
4 Technology 11.74%
5 Financials 10.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRH
1276
DELISTED
MONTPELIER RE HOLDINGS LTD
MRH
$271K 0.02%
9,301
-1,152
-11% -$32.1K
MRLN
1277
DELISTED
Marlin Business Services Corp
MRLN
$270K 0.02%
+10,700
New +$269K
SGNT
1278
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$270K 0.02%
+10,627
New +$240K
BANR icon
1279
Banner Corp
BANR
$2.44B
$269K 0.02%
6,000
-5,600
-48% -$226K
LAB icon
1280
Standard BioTools
LAB
$321M
$269K 0.02%
+7,020
New +$207K
PVH icon
1281
PVH
PVH
$4.09B
$269K 0.02%
1,981
-28,294
-93% -$3.6M
MCEP
1282
DELISTED
Mid-Con Energy Partners, LP
MCEP
$269K 0.02%
589
+75
+15% +$35.3K
UDR icon
1283
UDR
UDR
$12.4B
$268K 0.02%
+11,489
New +$275K
ULTI
1284
DELISTED
Ultimate Software Group Inc
ULTI
$268K 0.02%
1,749
-1,432
-45% -$216K
SVU
1285
DELISTED
SUPERVALU Inc.
SVU
$268K 0.02%
5,261
-8,947
-63% -$441K
METR
1286
DELISTED
METRO BANCORP, INC COMMON STOCK
METR
$268K 0.02%
12,444
-1,700
-12% -$36.9K
MANU icon
1287
Manchester United
MANU
$3.88B
$267K 0.02%
17,200
+5,600
+48% +$92K
RBA icon
1288
RB Global
RBA
$20.7B
$266K 0.02%
11,610
-7,380
-39% -$151K
RFP
1289
DELISTED
Resolute Forest Products Inc.
RFP
$266K 0.02%
16,619
-1,322
-7% -$19.5K
PVTB
1290
DELISTED
PrivateBancorp Inc
PVTB
$266K 0.02%
+9,209
New +$237K
ISIL
1291
DELISTED
Intersil Corp
ISIL
$266K 0.02%
23,205
+11,184
+93% +$122K
CNL
1292
DELISTED
CLECO CRP (HOLDING CO)
CNL
$266K 0.02%
5,716
-2,689
-32% -$124K
NLY icon
1293
Annaly Capital Management
NLY
$17.1B
$265K 0.02%
+6,656
New +$289K
NTWK icon
1294
NetSol Technologies
NTWK
$51.7M
$265K 0.02%
45,500
+2,000
+5% +$12.5K
PRTA icon
1295
Prothena Corp
PRTA
$444M
$265K 0.02%
+10,000
New +$251K
IMPV
1296
DELISTED
Imperva, Inc.
IMPV
$265K 0.02%
5,497
-1,003
-15% -$42.2K
WSTC
1297
DELISTED
West Corporation
WSTC
$265K 0.02%
10,300
-2,800
-21% -$65.7K
PRXL
1298
DELISTED
Parexel International Corp
PRXL
$265K 0.02%
+5,869
New +$269K
ALE
1299
DELISTED
Allete
ALE
$264K 0.02%
5,300
-155
-3% -$7.68K
CBI
1300
DELISTED
Chicago Bridge & Iron Nv
CBI
$264K 0.02%
+3,180
New +$241K
50 51
52
53 54

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PRA
Pine Ridge Advisers New York $1.62B AUM 16.97% 1-Year Est. Return
CC
Covalis Capital London, United Kingdom $1.63B AUM 27.84% 1-Year Est. Return

GSA Capital Partners's Q4 2013 Portfolio in Review

As of Q4 2013, GSA Capital Partners held 1,966 positions worth $1.27B, up 0.08% from $1.26B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.

GSA Capital Partners withdrew a net $81.4M in Q4 2013, closing 359 positions and reducing 590 holdings. Its most notable exit was CVS Health, an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, GSA Capital Partners opened a new position in Pfizer worth $6.69M.

  • GSA Capital Partners's largest Q4 2013 buy was Pfizer: 230,320 shares worth $6.69M.
  • GSA Capital Partners added most to CME Group in Q4 2013, an estimated $7.23M increase.
  • GSA Capital Partners's biggest Q4 2013 reduction was HP, cutting an estimated $8.76M.
  • GSA Capital Partners fully exited CVS Health in Q4 2013, selling an estimated $12.3M.
  • GSA Capital Partners's ten largest holdings make up 5.6% of its $1.27B portfolio in Q4 2013.
  • GSA Capital Partners opened 431 new positions and closed 359 in Q4 2013.
  • GSA Capital Partners's portfolio value rose 0.08% quarter-over-quarter to $1.27B.

Based on GSA Capital Partners's 13F filing for Q4 2013, filed 12 Feb 2014.